These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11757681)

  • 1. Quantification of receptor interactions using binding methods.
    Lazareno S
    J Recept Signal Transduct Res; 2001; 21(2-3):139-65. PubMed ID: 11757681
    [No Abstract]   [Full Text] [Related]  

  • 2. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    MacKay D
    J Pharm Pharmacol; 1978 May; 30(5):312-3. PubMed ID: 26747
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental procedure for estimating the dissociation constant of noncompetitive interactants. Part I.
    Orsetti M
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):51-7. PubMed ID: 3718726
    [No Abstract]   [Full Text] [Related]  

  • 4. [Theoretical studies on interactions between pharmacon models and ionic receptor binding sites (author's transl)].
    Höltje HD
    Arch Pharm (Weinheim); 1978 Jan; 311(1):2-11. PubMed ID: 626563
    [No Abstract]   [Full Text] [Related]  

  • 5. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 6. pA2 and receptor differentiation: a statistical analysis of competitive antagonism.
    Tallarida RJ; Cowan A; Adler MW
    Life Sci; 1979 Aug; 25(8):637-54. PubMed ID: 388133
    [No Abstract]   [Full Text] [Related]  

  • 7. [Receptors; from idea to reality].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1983 Jul; 127(28):1235-8. PubMed ID: 6310420
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of competitive ligand binding results in QSAR studies.
    Gómez-Jeria JS
    Farmaco Sci; 1985 May; 40(5):299-302. PubMed ID: 4007152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs and endogenous ligands compete for receptor occupancy.
    Colburn WA
    J Clin Pharmacol; 1994 Dec; 34(12):1148-52. PubMed ID: 7738208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-linear coupling between receptor occupancy and biologic effect as a requirement for a higher drug efficacy.
    Swillens S; Dumont JE
    Mol Cell Endocrinol; 1980 Dec; 20(3):233-42. PubMed ID: 6258999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The classification of drugs and drug receptors in isolated tissues.
    Kenakin TP
    Pharmacol Rev; 1984 Sep; 36(3):165-222. PubMed ID: 6093156
    [No Abstract]   [Full Text] [Related]  

  • 12. Computerized graphic methods for determining dissociation constants of agonists, partial agonists, and competitive antagonists in isolated smooth muscle preparations.
    Zaborowsky BR; McMahan WC; Griffin WA; Norris FH; Ruffolo RR
    J Pharmacol Methods; 1980 Sep; 4(2):165-78. PubMed ID: 7453193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady state variables in the guarded receptor hypothesis.
    Schanne OF
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H2098-100. PubMed ID: 1721503
    [No Abstract]   [Full Text] [Related]  

  • 14. On the parabolic relationship between biological activity and hydrophobicity of drugs: transport or protein binding?
    Franke R
    Experientia Suppl; 1976; 23():25-30. PubMed ID: 954940
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is chirality a key to stereoselective drug action?].
    Cegła M; Duszyńska B
    Postepy Hig Med Dosw; 1990; 44(4-6):279-98. PubMed ID: 2097612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of pharmacokinetics.
    Tognoni G; Bellantuono C; Bonati M; D'Incalci M; Gerna M; Latini R; Mandelli M; Porro MG; Riva E
    Clin Pharmacokinet; 1980; 5(2):105-36. PubMed ID: 6102499
    [No Abstract]   [Full Text] [Related]  

  • 17. [Data for the modeling of drug-receptor interaction, taking into consideration additives or combined active ingredients in the formulation].
    Bozzay J; Békefi E; Dávid A; Rusznák I
    Acta Pharm Hung; 1983 May; 53(3):97-105. PubMed ID: 6880768
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drugs: molecular pharmacology, sites of action and drug receptors].
    Astier A
    Soins; 1984 Oct; (439):13-25. PubMed ID: 6569695
    [No Abstract]   [Full Text] [Related]  

  • 19. [A microcomputer program for the analysis of the drug-receptor bond using radioligands].
    García AJ; Ríus F; López DR; Martos F; de la Cruz JP; Gómez JA; Sánchez de la Cuesta F
    Arch Farmacol Toxicol; 1986 Apr; 12(1):71-82. PubMed ID: 3755582
    [No Abstract]   [Full Text] [Related]  

  • 20. [General pharmacodynamic principles].
    Bernard JP; Opdal MS; Khiabani H
    Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2107-9. PubMed ID: 16932780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.